Blogs
- All
- About us
- Campaigning
- Dementia info
- Fundraising
- Living with dementia
- Our scientists
- Our supporters
- Research
Three key take-aways from this year’s Clinical Trials in Alzheimer’s Disease (CTAD) conference in Boston
Our Executive Director of Research and Partnerships, Dr Susan Kohlhaas, reflects back on the Clinical Trials in Alzheimer’s Disease (CTAD) conference and shares her excitement about what’s to come for dementia research.
How you can help Alzheimer’s Research UK this Christmas: Six Supporter Stories
The festive season can be a wonderful time to share food, exchange presents and spend quality moments with your loved ones. But Christmas can have so much more meaning when we choose to give something back to a cause close to our hearts. We know that if nothing changes, 1 in 2 people will have…
Understanding diabetes and brain health
Learn more about the link between diabetes and dementia, and what you can do to help protect your brain.
Spotting early signs that could be dementia – when should you worry?
What to lookout for if you’re worried about your loved ones and dementia this Christmas: Dr Tim Rittman explains the early signs and what to do next.
Reflecting on a groundbreaking year
This week, we published our Annual Report for the 2022/23 financial year, and I couldn’t be more excited to reflect on such a momentous year for progress, both in dementia research and at Alzheimer’s Research UK.
Blood Biomarker Challenge: If we can fix dementia diagnosis, we open the door for a cure
In May, we were awarded £5m by players of Peoples Postcode Lottery, alongside Alzheimer’s Society and the National Institute for Health and Care Research, to help revolutionise dementia diagnosis in the UK. We thought we’d take a look at what’s been happening since the Spring to get this project off the ground.
How does dementia cause death?
After you or a loved one receive a diagnosis of dementia, it’s natural to have questions about the future. We understand that this can be an overwhelming time, so only read this information if you feel ready. It’s also OK if you decide you never want to read it. For information about dementia, contact our…
Three lessons from our latest Dementia Attitudes Monitor
Find out what we learnt about public understandings of dementia in our latest Dementia Attitudes Monitor.
New estimates suggest dementia cases are set to rise – are they reliable?
New evidence suggests that dementia cases are set to rise higher than previously estimated in England and Wales by 2040. Factors behind this increase require urgent and comprehensive action to change this concerning outlook.
Lack of vision for dementia at party conferences
The lack of focus on dementia from the political parties at the 2023 party conferences is a missed opportunity to engage in a dialogue and develop meaningful policies to address dementia. We can, and must, demand better.
Frontotemporal dementia (FTD) – what is it and how close is a cure?
Alzheimer’s Research UK’s experts discuss what we know so far about frontotemporal dementia (FTD).
Biotech founded on charity science raises £48 million to develop next-generation dementia treatments
AstronauTx, working with the UCL DDI, has received funding to develop more treatments for dementia causing diseases like Alzheimer’s
Protecting brain health: supporting the search for a cure
Following the launch of our new Change The Ending campaign, we take a look at how brain health supports our search for a cure.
“I’m going the extra mile for dementia research. Now it’s your turn, Prime Minister”
Read Louis Alexander’s letter to the Prime Minister, as he runs seven marathons on seven continents for Alzheimer’s Research UK.
What has research revealed about frontotemporal dementia?
New research sheds light on the mechanisms behind FTD, which could help to find new treatments.
Holding on to what matters and risking a lot to do so – what do people want from new dementia treatments?
There has never been a more pressing need to understand what outcomes people want from new dementia treatments, and the level of risk they’d be willing to take in order to benefit from such drugs.
Dementia impacts too many of us – but we will change the ending
As we set out to Change The Ending for everyone affected by dementia, our chief executive, Hilary Evans, reflects on recent progress and why we’re so hopeful for the future.
How Alzheimer’s changed our lives, and why we want to change the ending for others
Alison Littleford’s husband Frank was diagnosed with Alzheimer’s disease in 2020. To coincide with the launch of our latest Connections film featuring their story and our Change The Ending campaign, Alison shares her thoughts on how Frank’s Alzheimer’s impacts their lives.
Leading the search for a cure
Scientist Fiona Ducotterd discusses her work and tells us why she’s so optimistic for the future of dementia research.
Time to clear the air on pollution and dementia
We review the latest evidence linking air pollution and dementia, and how it reinforces the case for urgent government action to improve the quality of the air we breathe.
The science behind staying sharp
Staying sharp is one of our three simple rules for better brain health, but what does this mean in practice?
How does your hearing affect dementia risk?
In 2020, a study reviewing risk factors for dementia suggested people with unaddressed midlife hearing loss may be up to five times more likely to have the condition than those without hearing loss.
A day in the life of a brain health researcher
Dementia researchers are making new discoveries all the time, helping us better understand how to look after our brains. But have you ever wondered what they get up to every day?
Walk for a cure – and for your brain health
Our supporter Hat Hewitt explains why it was important for her to walk for a cure – and how walking is part of her toolkit for looking after her brain health.
A sense of momentum, excitement, and pride – my reflections on AAIC 2023
After four intense days, our chief executive, Hilary Evans, reflects on the 2023 Alzheimer’s Association International Conference, which brought home the really heartening progress the research community are making against dementia.
